Both in Pharmaceuticals
SCYNEXIS vs NanoViricides
Over the past year SCYX returned −23.8% and NNVC returned −27.7%; their daily moves had a correlation of 0.05.
SCYX −23.8% NNVC −27.7%Growth of $1, one year, split-adjusted
| Metric | SCYX | NNVC |
|---|---|---|
| Price | $3.84 | $1.38 |
| Market cap | $38.2M | $35.2M |
| Today | −2.54% | −3.50% |
| 1 month | −20.7% | −1.4% |
| 6 months | −51.1% | −5.5% |
| Year to date | −24.1% | +22.1% |
| 1 year | −24.8% | −32.0% |
| Revenue growth (YoY) | −82.8% | — |
| Gross margin | 100.0% | — |
| Net margin | 3147.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $54.1M | $2.8M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 90.2% |
| Short % of float | 4.7% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).